Publicaciones (142) Publicaciones de LUIS DAVID VIVAS BALCONES

2024

  1. A debate. «Orbitando» en torno al abordaje de la angina estable. Perspectiva del clínico

    REC: Interventional Cardiology, Vol. 6, Núm. 3, pp. 238-239

  2. Adherence to periprocedural antithrombotic treatment recommendations and its prognostic impact in patients with high ischemic and hemorrhagic risk

    Revista Espanola de Cardiologia

  3. Cardiovascular considerations on recreational scuba diving. SEC-Clinical Cardiology Association/SEC-Working Group on Sports Cardiology consensus document

    Revista Espanola de Cardiologia

  4. Impact of inappropriate management of antithrombotic treatment in patients undergoing oral procedures

    Medicina Clinica, Vol. 162, Núm. 3, pp. 138-139

  5. Incidence and clinical impact of inappropriate periprocedural and perioperative management of antiplatelet therapy

    Medicina Clinica, Vol. 163, Núm. 7, pp. 336-343

  6. Linfoma cardíaco primario: utilidad de la imagen cardíaca en el diagnóstico

    Revista de Ecocardiografía práctica y otras Técnicas de Imagen Cardíaca (RETIC), Vol. 7, Núm. 2, pp. 16-19

  7. Periprocedural use of antithrombotic therapy in interventional cardiology in Spain: are we doing better than other specialties?

    Revista Espanola de Cardiologia, Vol. 77, Núm. 8, pp. 701-703

  8. Practical approach for atrial cardiomyopathy characterization in patients with atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 77, Núm. 8, pp. 656-666

  9. Practical use of new therapies for the management of dyslipidaemias. Consensus SEC/SEA/SEEN/SEMFYC/SEMERGEN/SEMG/SEN/SEACV/S.E.N.

    REC: CardioClinics, Vol. 59, Núm. 4, pp. 310-321

2023

  1. Effects of intravenous lysine acetylsalicylate versus oral aspirin on platelet responsiveness in patients with ST-segment elevation myocardial infarction: the ECCLIPSE-STEMI trial

    Journal of Thrombosis and Thrombolysis, Vol. 55, Núm. 2, pp. 203-210

  2. Prospective observational registry of perioperative and periprocedural management of antithrombotic therapy in “real world”: the REQXAA study

    Revista Espanola de Cardiologia, Vol. 76, Núm. 9, pp. 729-738

  3. Selection of the best of 2022 in clinical cardiology and cardiovascular pharmacotherapy

    REC: CardioClinics, Vol. 58, pp. S49-S54

  4. Should atrial fibrillation be considered a vascular disease? The need for a comprehensive vascular approach

    Expert Review of Cardiovascular Therapy

2022

  1. Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes

    Journal of Clinical Medicine, Vol. 11, Núm. 11

  2. Apical left ventricular pseudoaneurysm: Diagnosis by multimodal cardiac imaging

    Cardiology Journal

  3. Comments on the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice

    Revista Española de Cardiología (English Edition), Vol. 75, Núm. 5, pp. 364-369

  4. Current trends on antithrombotic therapy

    REC: CardioClinics

  5. Edoxaban: from clinical trials to real world evidence

    REC: CardioClinics, Vol. 57, Núm. 1, pp. 4-6

  6. PROMOSALUD: Recomendaciones SEPA para la detección precoz desde la clínica dental del riesgo de padecer diabetes o hipertensión arterial col.

    Gaceta dental: Industria y profesiones, Núm. 351, pp. 16-52

  7. Polypill Strategy in Secondary Cardiovascular Prevention

    The New England journal of medicine, Vol. 387, Núm. 11, pp. 967-977